Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C18:1 Oleyl (Octadecenoyl) acylcarnitine

Immunology & Autoimmune

C18:1-ACOctadecenoylcarnitineOleylcarnitine (C18:1)

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures C18:1 oleylcarnitine, a long‑chain acylcarnitine formed when the fatty acid oleic acid is linked to carnitine. Acylcarnitines help move fatty acids into mitochondria, where they are used to make energy, especially when you are fasting or ill.

It is usually performed as part of an acylcarnitine profile by tandem mass spectrometry on a dried blood spot, serum, or plasma. Your clinician may order it alone or with related markers to better understand how your body is handling long‑chain fats.

Why it matters

C18:1 oleylcarnitine can be higher when there are problems transporting or processing long‑chain fats in mitochondria. This pattern is seen in certain inborn errors of metabolism, such as carnitine palmitoyltransferase II deficiency or carnitine‑acylcarnitine translocase deficiency, and may also shift during serious illness, prolonged fasting, or muscle injury. In newborns, it helps evaluate abnormal screening results or symptoms such as poor feeding, lethargy, or low blood sugar.

Your provider may use this result to decide if more metabolic testing is needed, to monitor a known fatty acid oxidation disorder, or to assess risk during periods of stress. Interpreting C18:1 together with other acylcarnitines and your clinical story improves accuracy and helps guide care.

Understanding your results

Your result is interpreted in the context of age‑specific reference intervals, the collection conditions, and other acylcarnitine findings. A value above the expected range does not by itself diagnose a disease. Transient changes can occur with fasting, fever, hard exercise, or certain diets and supplements. Patterns that include other long‑chain acylcarnitines and specific ratios are often more informative than a single value.

If your value is higher than expected, your clinician may repeat testing when you are well fed, review medications and supplements, and order follow‑up studies such as a full acylcarnitine profile, free carnitine, urine organic acids, or genetic testing. If your value is within the expected range, that is generally reassuring, but your provider will still consider symptoms and other labs. Always discuss results with your care team to decide on next steps.

Reference ranges

0.10.34 umol/L
All sexes
0 days – 7 days
0.080.31 umol/L
All sexes
7 days – 1 month
00.28 umol/L
All sexes
1 month – 12 months
0.070.48 umol/L
All sexes
12 months – 13 years
0.080.45 umol/L
All sexes
13 years – 19 years
0.050.28 umol/L
All sexes
19 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C18:1 Oleyl (Octadecenoyl) acylcarnitine

  • Fasting and acute illness

    Prolonged fasting, infections, fever, or significant stress can increase long‑chain acylcarnitines, including C18:1, by shifting the body toward fat use for energy.

  • Dietary fat and parenteral nutrition

    High‑fat diets, lipid infusions, or medium‑chain triglyceride products can alter the acylcarnitine pattern and should be reported to the lab and your clinician.

  • Medications and supplements

    Drugs such as valproate, pivalate‑containing antibiotics, and carnitine supplements can affect acylcarnitine levels and may complicate interpretation.

  • Age, prematurity, and maternal factors

    Newborns and premature infants have evolving fatty acid metabolism. Maternal diet, medications, or metabolic conditions can influence infant results.

  • Timing relative to feeding and exercise

    Samples collected after prolonged fasting, vigorous exercise, or shortly after a large meal may show temporary changes that do not reflect baseline status.

  • Specimen handling and stability

    Improper drying or heat exposure of blood spots, or delays in processing serum or plasma, can degrade analytes and lead to misleading results.

2026

References

  1. McGill University Health Centre. (2018, December 04). C18:1 Oleyl_Octadecenoyl (Task CD 709483). Laboratory reference ranges.
  2. McGill University Health Centre. (2019, May 21). C18:1 Oleyl_Octadecenoyl (Task CD 709483). Laboratory reference ranges.
  3. McGill University Health Centre. (2019, June 07). C18:1 Oleyl_Octadecenoyl (Task CD 709483). Laboratory reference ranges.
  4. American College of Medical Genetics and Genomics. (2020). ACT Sheet: Elevated C16 and/or C18:1 acylcarnitines (suggestive of CPT-II or CACT deficiency).
  5. ARUP Consult. (2023). Acylcarnitine profile, blood spot and plasma: Test fact sheet.